Experimental assessment of 2-oxyindolin-3-glyoxylic acid derivative anticonvulsant effect

Cover Page


Cite item

Full Text

Abstract

Aim. To explore the anticonvulsant effect of 2-oxyindolin-3-glyoxylic acid derivative on the model of acute myoclonic seizures caused by pentylenetetrazol, picrotoxin and thiosemicarbazide.

Methods. Median effective dose (ED50) of 2-hydro-N-naphthalene-1-yl-2-(2-oxy-1,2-dyhydro-indole-3-ylidene)-acetamide diethyl ether was determined by the maximal electroshock test in experiments on adult Wistar rats of both gender. The effect of median effective dose prophylactic administration of the study medication and comparators - diazepam and sodium valproate - on chemo-induced epileptogenesis was explored. Introduction of proconvulsant drugs (pentylenetetrazol, picrotoxin and thiosemicarbazide) was accompanied by the development of seizures, which was estimated by the intensity of seizures (points), latent period of seizures onset (seconds), the number of convulsive attacks, seizures, duration (seconds) and the number of survived animals in each group.

Results. Median effective dose of 2-oxyindolin derivative was 12 mg/kg as measured by maximal electroshock test. This dose of the test compound, similar to diazepam, effectively reduced the severity of seizures caused by pentylenetetrazol, seen as the increased duration of latent period before the seizures onset by 1.9 times, decreased severity of seizures by 1.7 times, decreased number of seizures by 2.1 times, and decreased seizure duration by 2.3 times together with lower mortality. The prophylactic administration of the substance has extended the latent period of seizures by 2.0 times, significantly reduced the number, intensity and duration of seizures, decreased the mortality after administration of picrotoxin. Also, 2-oxyindolin derivative significantly increased the latent period of seizures onset and reduced the severity of seizures due to thiosemicarbazide. At that, the study substance was not inferior in anticonvulsant activity compared to the diazepam as the reference drug.

Conclusion. The dose of 12 mg/kg of 2-hydro-N-naphthalene-1-yl-2-(2-oxy-1,2-dyhydro-indole-3-ylidene)-acetamide was effective in preventing seizures associated with gamma-aminobutyric acid (GABA)-convulsants.

About the authors

R V Lutsenko

Ukranian Medical Stomatological Academy, Poltava, Ukraine

Author for correspondence.
Email: farmalu@mail.ru

References

  1. Болдырева С.Р., Ермаков А.Ю. Побочные действия антиэпилептических препаратов // Клин. эпилептол. - 2009. - №1. - С. 23-25.
  2. Джагацпанян И.А., Парокинян Р.Г., Назарян И.М. Экспериментальная характеристика нейротропного спектра некоторых антиэпилептических препаратов // Эксперим. и клин. фармакол. - 2003. - Т. 66, №6. - С. 20-23.
  3. Луценко Р.В. Производные 2-оксииндолин-3-глиоксиловой кислоты при резерпиновой модели депресии // Вестн. Винницкого гос. мед. ун-та. - 2011. - №1. - С. 123-125.
  4. Луценко Р.В., Бобирьов В.Н., Девяткина Т.А. Анксиолитическое действие производных 2-оксииндолин-3-глиоксиловой кислоты: компьютерное прогнозирование и экспериментальное подтверждение // Казанский мед. ж. - 2013. - Т. 94, №4. - С. 553-560.
  5. Рудакова И.Г., Белова Ю.А., Котов А.С. Фармакорезистентная эпилепсия поддаётся лечению // Вестн. эпилептол. - 2013. - №1. - С. 3-7.
  6. Хабриев Р.У. Руководство по экспериментальному (доклиническому) изучению новых фармакологических веществ. - М.: Медицина, 2005. - 832 с.
  7. Canoun-Poitrine F., Bastuji-Garin S., Alonso E. et al. Risk and prognostic factors of status epilepticus in the elderly: a case-control study // Epilepsia. - 2011. - Vol. 52, N 10. - P. 1849-1856. http://dx.doi.org/10.1111/j.1528-1167.2011.03168.x
  8. Clements S., Schreck C.B. Evidence that GABA mediates dopaminergic and serotonergic pathways associated with locomotor activity in juvenile chinook salmon (Oncorhynchus tshawytscha) // Behavor Neurosci. - 2004. - Vol. 118, N 1. - Р. 191-198.
  9. D’souza D.C., Gil R.B., Zuzarte E. et al. γ-Aminobutyric acid - serotonin interactions in healthy men: implications for network models of psychosis and dissociation // Biol. Psychiatry. - 2006. - Vol. 59. - P. 128-137. http://dx.doi.org/10.1016/j.biopsych.2005.06.020
  10. Gerald M.C., Riffee W.H. Acute and chronic effects of d- and 1-amphetamine on seizure susceptibility in mice // Eur. J. Pharmacol. - 1973. - Vol. 21, N 3. - P. 323-330. http://dx.doi.org/10.1016/0014-2999(73)90134-9
  11. Gregory L.H., Qian Z. Choosing the correct AED: from animal studies to the clinic // Pediatr. Neurol. - 2008. - Vol. 38, N 3. - Р. 151-162.
  12. Lopez-Meraz M.-L., Gonzalez-Trujano M.-E., Neri-Bazan L. et al. 5-HT1A-receptor agonists modify epileptic seizures in three experimental models in rats // Neuropharmacology. - 2005. - Vol. 49. - P. 367-375. http://dx.doi.org/10.1016/j.neuropharm.2005.03.020
  13. Oni J.O., Awe O.E., Olajide A.O. et al. Anticonvulsant and depressant activities of the seed extracts of Adnanthera parvonina // J. Natur. Products. - 2009. - Vol. 2. - Р. 74-80.
  14. Ren-Qi H., Cathy L., Bell-Horner M.I. et al. Pentylenetetrazole-induced inhibition of recombinant γ-aminobutyric acid type A (GABAA) receptors: mechanism and site of action // J. Pharm. Experim. Therap. - 2001. - Vol. 298, N 3. - Р. 986-995.
  15. Wesołowska A., Nikiforuk A., Chojnacka-Wójcik E. Anticonvulsant effect of the selective 5-HT1B receptor agonist CP 94253 in mice // Eur. J. Pharm. - 2006. - Vol. 541, N 1-2. - P. 57-63. http://dx.doi.org/10.1016/j.ejphar.2006.04.049

Supplementary files

Supplementary Files
Action
1. JATS XML

© 2015 Lutsenko R.V.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.





This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies